Pulse Biosciences, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | $600.0K | $800.0K | $500.0K | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $17.3M | $9.6M | $5.5M | $2.2M |
| SG&A Expense | $20.0M | $15.5M | $3.4M | $1.6M |
| Operating Income | $-37.5M | $-25.6M | $-9.5M | $-4.5M |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | $-37.5M | — | — | — |
| Income Tax Expense | — | — | — | $-1.7M |
| Net Income | $-37.5M | $-25.6M | $-9.5M | $-2.8M |
| Net Margin | — | — | — | — |
| EPS (Basic) | $-2.20 | $-1.73 | $-0.86 | $-0.37 |
| EPS (Diluted) | $-2.20 | $-1.73 | $-0.86 | $-0.37 |
| Shares Outstanding (Basic) | 20.6M | 16.8M | 13.3M | 7.6M |
| Shares Outstanding (Diluted) | 20.6M | 16.8M | 13.3M | 7.6M |
| Dividends Per Share | — | — | — | — |